首页> 外文OA文献 >The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer
【2h】

The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer

机译:趋化因子CCL20及其受体CCR6在人恶性肿瘤中的作用主要是结直肠癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chemokines are a superfamily of small chemotactic cytokines, which interact with their G-protein-coupled receptors. These interactions regulate multiple physiological functions, particularly tissue architecture and compartment-specific migration of white blood cells. It has been found that the chemokine/chemokine receptor system has been utilized by cancer cells for migration and metastasis. The chemokine receptor CCR6 is expressed in colorectal cancer and several other cancer types, and stimulation by its physiological chemokine ligand CCL20 has been reported to promote cancer cell proliferation and migration in vitro. Moreover, CCR6/CCL20 interactions apparently play a role in organ selective liver metastasis of colorectal cancer. Here, we review the literature on expression patterns of CCL20 and CCR6 and their physiological interactions as well as the currently presumed role of CCR6 and CCL20 in the formation of colorectal cancer liver metastasis, providing a potential basis for novel treatment strategies.
机译:趋化因子是小趋化性细胞因子的超家族,其与G蛋白偶联受体相互作用。这些相互作用调节多种生理功能,特别是组织结构和白细胞的区室特异性迁移。已经发现趋化因子/趋化因子受体系统已被癌细胞用于迁移和转移。趋化因子受体CCR6在大肠癌和其他几种癌症类型中表达,据报道其生理趋化因子配体CCL20的刺激可促进癌细胞在体外的增殖和迁移。此外,CCR6 / CCL20相互作用显然在结直肠癌的器官选择性肝转移中起作用。在这里,我们审查有关CCL20和CCR6的表达模式及其生理相互作用以及目前推测的CCR6和CCL20在结直肠癌肝转移形成中的作用的文献,为新的治疗策略提供了潜在的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号